Qatar Red Crescent Society’s Patient Support Fund Covers Treatment Costs For Needy Patients

Qatar Red Crescent Society’s (QRCS) Patient Support Fund is covering treatment costs for poor patients in Qatar. According to the QRCS website, 124 patients with chronic diseases received the much-needed treatment during the past week, to avoid any serious health complications in case of delay. These included follow-up patients with heart disease, kidney failure, cancer, rheumatism, and autoimmune disorders. All the necessary precautions were strictly taken to prevent coronavirus infection risks.

This year, the Patient Support Fund has planned to reach 2,000 patients, in addition to providing social health support and other charitable services for up to 12,000 persons, with a total budget of QR 11,230,000.

Over the past year, 1,605 poor patients were covered, 9,000 persons received social health support, and 3,395 persons benefited from the Cordiality Iftar implemented at hospitals during the holy month of Ramadan.

The Patient Support Fund works in cooperation with Hamad Medical Corporation (HMC). Other partners include AbbVie Biopharmaceuticals GmbH, Qatar Center for Organ Transplantation (QCOT), HMC Department of Gastroenterology, and Roche.

The Patient Support Fund is a humanitarian program that addresses the needs of poor patients whose lives are badly affected by health problems. By providing the necessary medications and medical services, it helps to promote solidarity and compassion among the rich and the poor, with no discrimination on the basis of colour, race, or religion.

Funded mainly from the revenue of charity paid by individual and institutional donors in Qatar, it ultimately seeks to enhance public health in Qatar, in light of the national health strategies, towards the human development goals of Qatar National Vision 2030.

For more information, please visit: QRCS

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button